NRX Pharmaceuticals Announces Board Resignation and New Nominee

TipRanks8minutes ago

Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel

Dow JonesJan 14 08:03 ET

Express News | NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces It Has Filed an Application With Nasdaq to Uplist to the Nasdaq Global Market From the Nasdaq Capital Market

ReutersJan 13 08:04 ET

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces It Has Filed an Application With NASDAQ to Uplist to the NASDAQ Global Market From the NASDAQ Capital Market

PR NewswireJan 13 08:04 ET

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the...

PR NewswireJan 7 08:07 ET

NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk

WSJJan 6 19:00 ET